FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2995341738> ?p ?o ?g. }

• W2995341738 endingPage "57" @default.
• W2995341738 startingPage "50" @default.
• W2995341738 abstract "Tumor necrosis factor alpha (TNF-α) is one of the key inflammatory cytokines in the pathogenesis of psoriasis and psoriatic arthritis, and its inhibition with genetically engineered biological drugs ensures control of the main symptoms of these diseases. Certolizumab pegol is a PEGylated (linked to polyethylene glycol) Fab’ fragment of a monoclonal antibody that inhibits human TNF-α. It is approved for treatment of moderate to severe plaque psoriasis and psoriatic arthritis. This review summarizes the results of randomized clinical trials of efficacy and safety of certolizumab pegol in plaque psoriasis (CIMPASI 1, CIMPASI 2, and CIMPACT) and psoriatic arthritis (Rapid-PsA). The represented data demonstrate high efficacy of certolizumab pegol is bio-naïve patients and in patients previously exposed to other TNF inhibitors or IL17 inhibitors. The absence of the Fc-fragment in certolizumab pegol ensures minimal to no placental transfer of the drug and enables its usage during the entire pregnancy. Conflict of interest: the authors state that there is no potential conflict of interest requiring disclosure in this article." @default.
• W2995341738 created "2019-12-26" @default.
• W2995341738 creator A5012829095 @default.
• W2995341738 creator A5020595851 @default.
• W2995341738 creator A5028543991 @default.
• W2995341738 creator A5031853679 @default.
• W2995341738 creator A5035172216 @default.
• W2995341738 creator A5047276997 @default.
• W2995341738 creator A5066054039 @default.
• W2995341738 creator A5066305320 @default.
• W2995341738 creator A5071281775 @default.
• W2995341738 creator A5073703734 @default.
• W2995341738 creator A5087841320 @default.
• W2995341738 date "2019-12-17" @default.
• W2995341738 modified "2023-10-01" @default.
• W2995341738 title "Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis" @default.
• W2995341738 cites W1572018981 @default.
• W2995341738 cites W1984455842 @default.
• W2995341738 cites W1997106678 @default.
• W2995341738 cites W2037433854 @default.
• W2995341738 cites W2071843728 @default.
• W2995341738 cites W2083707884 @default.
• W2995341738 cites W2095169919 @default.
• W2995341738 cites W2139788459 @default.
• W2995341738 cites W2152559121 @default.
• W2995341738 cites W2154515402 @default.
• W2995341738 cites W2161099242 @default.
• W2995341738 cites W2167795826 @default.
• W2995341738 cites W2748832895 @default.
• W2995341738 cites W2764022867 @default.
• W2995341738 cites W2789473281 @default.
• W2995341738 cites W2793950156 @default.
• W2995341738 cites W2797132528 @default.
• W2995341738 cites W2797238574 @default.
• W2995341738 cites W2808115344 @default.
• W2995341738 cites W2911209682 @default.
• W2995341738 cites W2912335857 @default.
• W2995341738 cites W2924895007 @default.
• W2995341738 cites W2936006980 @default.
• W2995341738 cites W2986283446 @default.
• W2995341738 cites W2986312172 @default.
• W2995341738 cites W4211202219 @default.
• W2995341738 cites W4241915332 @default.
• W2995341738 doi "https://doi.org/10.25208/0042-4609-2019-95-5-50-57" @default.
• W2995341738 hasPublicationYear "2019" @default.
• W2995341738 type Work @default.
• W2995341738 sameAs 2995341738 @default.
• W2995341738 citedByCount "2" @default.
• W2995341738 countsByYear W29953417382021 @default.
• W2995341738 crossrefType "journal-article" @default.
• W2995341738 hasAuthorship W2995341738A5012829095 @default.
• W2995341738 hasAuthorship W2995341738A5020595851 @default.
• W2995341738 hasAuthorship W2995341738A5028543991 @default.
• W2995341738 hasAuthorship W2995341738A5031853679 @default.
• W2995341738 hasAuthorship W2995341738A5035172216 @default.
• W2995341738 hasAuthorship W2995341738A5047276997 @default.
• W2995341738 hasAuthorship W2995341738A5066054039 @default.
• W2995341738 hasAuthorship W2995341738A5066305320 @default.
• W2995341738 hasAuthorship W2995341738A5071281775 @default.
• W2995341738 hasAuthorship W2995341738A5073703734 @default.
• W2995341738 hasAuthorship W2995341738A5087841320 @default.
• W2995341738 hasBestOaLocation W29953417381 @default.
• W2995341738 hasConcept C126322002 @default.
• W2995341738 hasConcept C17991360 @default.
• W2995341738 hasConcept C203014093 @default.
• W2995341738 hasConcept C2776215756 @default.
• W2995341738 hasConcept C2776260265 @default.
• W2995341738 hasConcept C2777077863 @default.
• W2995341738 hasConcept C2777138892 @default.
• W2995341738 hasConcept C2779722408 @default.
• W2995341738 hasConcept C2780564577 @default.
• W2995341738 hasConcept C535046627 @default.
• W2995341738 hasConcept C71924100 @default.
• W2995341738 hasConcept C98274493 @default.
• W2995341738 hasConceptScore W2995341738C126322002 @default.
• W2995341738 hasConceptScore W2995341738C17991360 @default.
• W2995341738 hasConceptScore W2995341738C203014093 @default.
• W2995341738 hasConceptScore W2995341738C2776215756 @default.
• W2995341738 hasConceptScore W2995341738C2776260265 @default.
• W2995341738 hasConceptScore W2995341738C2777077863 @default.
• W2995341738 hasConceptScore W2995341738C2777138892 @default.
• W2995341738 hasConceptScore W2995341738C2779722408 @default.
• W2995341738 hasConceptScore W2995341738C2780564577 @default.
• W2995341738 hasConceptScore W2995341738C535046627 @default.
• W2995341738 hasConceptScore W2995341738C71924100 @default.
• W2995341738 hasConceptScore W2995341738C98274493 @default.
• W2995341738 hasIssue "5" @default.
• W2995341738 hasLocation W29953417381 @default.
• W2995341738 hasOpenAccess W2995341738 @default.
• W2995341738 hasPrimaryLocation W29953417381 @default.
• W2995341738 hasRelatedWork W1883428297 @default.
• W2995341738 hasRelatedWork W2013637744 @default.
• W2995341738 hasRelatedWork W2118788870 @default.
• W2995341738 hasRelatedWork W2146304976 @default.
• W2995341738 hasRelatedWork W2200472334 @default.
• W2995341738 hasRelatedWork W2240357112 @default.
• W2995341738 hasRelatedWork W2406608300 @default.
• W2995341738 hasRelatedWork W2901619209 @default.

• next